CAS 928672-86-0 Purity ≥99.0% (HPLC) API

CAS: 928672-86-0 Appearance: White Powder Purity: ≥99.0% (HPLC)  A SGLT-2 inhibitor in the treatment of Patients with Type 2 Diabetes Mellitus API High Quality, Commercial Production Inquiry: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture
Item Specifications
Appearance White Powder
Identification HPLC/NMR
Solubility Very Soluble in Methanol; Soluble in Ethanol, Acetonitrile; Slightly Soluble in Water
Purity / Analysis Method  ≥99.0% (HPLC)
Individual Impurity ≤0.10%
Total Impurities ≤0.50%
Residual Solvents
Methanol ≤3000ppm
Ethanol ≤5000ppm
Acetonitrile ≤400ppm
Dichloromethane ≤600ppm
Ethyl Acetate ≤5000ppm
THF ≤720ppm
Toluene ≤890ppm
Test Standard Chinese Pharmacopoeia (CP); Enterprise Standard
Usage Active Pharmaceutical Ingredient (API); SGLT-2 inhibitors Type 2 Diabetes  

Description:

Specifications:

Package & Storage:

CAS Number 928672-86-0
CAT Number RF-API22
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C24H27FO6S
Molecular Weight 462.53
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

It is a drug of the gliflozin class or subtype 2 sodium-glucose transport inhibitors (SGLT2) used for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. It is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. In March 2013, It became the first SGLT2 inhibitor to be approved in the United States. To mention the advantage, this drug helps patients to reduce blood sugars without increasing the likelihood of gaining weight as long as a healthy, balanced diet is followed and regular exercise taken. In addition, It has a broad prospect due to its significant antiobesity effects and few hypoglycemic events. 

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours